# Tata Memorial Centre: Phase 3 study in Radiation Proctitis, Gastrointestinal Hemorrhage (200 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Tata Memorial Centre |
| Sponsor type | Academic and hospital |
| Study | A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract Bleeding |
| NCT ID | NCT07837713 |
| Phase | Phase 3 |
| Status | not yet recruiting |
| Conditions | Radiation Proctitis; Gastrointestinal Hemorrhage; Radiation Injuries |
| Intervention types | drug |
| Target enrollment | 200 |
| Site countries | India |
| Posted | 2026-09-23 |
| Planned start | 2026-09-15 |
| Event | Newly registered study |
| Event date | 2026-09-23 |

## Why this score
- Phase 3: multi-site, larger budget.
- 200 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07837713). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.